Cargando…
The pivotal role of cholesterol absorption inhibitors in the management of dyslipidemia
Elevated low-density lipoprotein (LDL)-cholesterol is associated with a significantly increased risk of coronary heart disease. Ezetimibe is the first member of a new class of selective cholesterol absorption inhibitors. It impairs the intestinal reabsorption of both dietary and hepatically excreted...
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
BioMed Central
2004
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC524501/ https://www.ncbi.nlm.nih.gov/pubmed/15471540 http://dx.doi.org/10.1186/1476-511X-3-22 |